Endocrine Disruption for Endocrinologists (and Others)
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
On June 3, 2005, The Endocrine Society held an unprecedented full-day forum on endocrine-disrupting chemicals (EDCs). Sponsored through the generosity of The Endocrine Society, the National Institute of Environmental Health Sciences, and the Environmental Protection Agency, this forum brought together basic scientists, physicians, clinical scientists, epidemiologists, and others interested in discussing and learning about the importance of endocrine disruption in the context of endocrinology. This first-ever supplement to Endocrinology contains a special series of eight review articles on endocrine disruption, seven of which are authored by the forum’s speakers, and the eighth providing an evolutionary perspective to epigenetics in endocrine disruption. As forum organizers, the three of us developed and directed the programming, but more importantly, we have this opportunity to summarize and integrate the outcomes of the forum for the endocrine community. The review articles that follow this introduction make it clear that the topic of endocrine disruption is pertinent to all endocrinologists. Moreover, a wide variety of chemicals exert endocrine-disrupting actions, including but not limited to industrial chemicals, pesticides, plant phytoestrogens, metals, and other environmental substances. Here we provide an overview of the highlights of the science at the forum, a synopsis of the open discussion, and we make recommendations for future research. Three major themes were recurrent at the forum. First, the timing of exposure to exogenous hormonally active substances, i.e. endocrine disruptors, is critical to the outcome of that exposure, with early lifetime exposures (e.g. fetal or early postnatal) particularly detrimental because they produce permanent effects (1). Second, EDCs often act at environmentally relevant doses, have complex dose-response curves, and involve cellular mechanisms that often occur through multiple signaling pathways (2). Third, effects of EDCs not only impact the exposed individual but may also be transmitted to subsequent generations through the germ line, probably via epigenetic modifications (3–5). These topics are discussed here briefly; for details, we refer our readers to the review article series that follows. This hypothesis postulates that exposures to exogenous (and in some cases aberrant exposure to endogenous) substances during developmental periods predisposes an individual to develop a disorder or disease much later in life (1, 6). Those life stages most vulnerable to endocrine disruption are the prenatal and early postnatal periods, because these are times when organ and neural systems are changing most rapidly. Pubertal and perimenopausal periods may also be sensitive windows of exposure because of the changing hormonal effects during these periods (7). Furthermore, research in endocrine disruption is focusing increasingly on the interactions of these early exposures with the individual’s nutrition and genetics, including genetic polymorphisms and epigenetic modulation of gene activity. Thus, exposure of one individual to an environmental toxicant may have little effect, whereas another individual with identical exposure will develop overt disease or dysfunctions. Differences can be caused by the individuals’ different genetic makeup as well as other lifetime exposures that can ensue. In this supplement to Endocrinology, the papers from the groups of Skinner (8), Crews and McLachlan (9), Fenton (10), Blumberg (11), Korach (12), Newbold (13), Petersen (14), and Welshons and vom Saal (15) provide strong examples of the fetal/developmental basis hypothesis for systems ranging from neural, mammary gland, and reproductive tract of males and females as well as neuroendocrine systems. Moreover, other studies show that this hypothesis is applicable to thyroid (16, 17), stress (18), growth (19), and metabolism and obesity (20). Effects of endocrine disruption may be manifested across multiple generations (i.e. transgenerationally), but the mechanisms often do not involve an overt gene mutation. Rather, epigenetic effects of EDCs may occur whereby an action is exerted upon the genome to alter gene expression, by methylation without modifying the sequence of the DNA itself (21) and/or histone modifications such as acetylation (22). Such changes can affect gene function and can be transmitted from generation to generation with a higher penetrance than mutations themselves (3). Such mechanisms of EDCs are difficult to diagnose through simple means such as DNA sequencing. The timing of these exposures is crucial, because the receipt of a signal at an inappropriate developmental period may permanently influence gene expression by an epigenetic mechanism. Fortunately, new technology exists to study DNA methylation and acetylation that will likely be essential to identify public health consequences of EDC exposures (23). That epigenetic effects are inherited across multiple generatio
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epigenetic Transgenerational Actions of Endocrine Disruptors and Male Fertility
Anway, M. D., Cupp, A. S., Uzumcu, M., & Skinner, M. K. (2005) · Science · doi:10.1126/science.1108190 · Cited by 2,563
Epigenetic Transgenerational Actions of Endocrine Disruptors
Anway, M. D., & Skinner, M. K. (2006) · Endocrinology · doi:10.1210/en.2005-1058 · Cited by 455
Epigenomics: Genome-Wide Study of Methylation Phenomena
(2002) · Current Issues in Molecular Biology · doi:10.21775/cimb.004.111 · Cited by 150
Cited by
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
Diamanti-Kandarakis, E., Bourguignon, J.-P., Giudice, L. C., Hauser, R., Prins, G. S., Soto, A. M., Zoeller, R. T., & Gore, A. C. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0002 · Cited by 4,585
Self-citationMetabolism disrupting chemicals and metabolic disorders
Heindel, J. J., Blumberg, B., Cave, M., Machtinger, R., Mantovani, A., Mendez, M. A., Nadal, A., Palanza, P., Panzica, G., Sargis, R., et al. (2017) · Reproductive Toxicology · doi:10.1016/j.reprotox.2016.10.001 · Cited by 1,101
“Independent replication of results is the accepted standard for assessing validity of findings in research, thus the issue of non-replication of findings in some EDC studies must take into account the issues described above (sensitivity of endpoint, sex-specific effects, influence of animal feed), as well as the appro…”
InfluentialSelf-citationDevelopmental origins of metabolic diseases
Hoffman, D. J., Powell, T. L., Barrett, E. S., & Hardy, D. B. (2021) · Physiological Reviews · doi:10.1152/physrev.00002.2020 · Cited by 466
The effects of prenatal PCBs on adult female paced mating reproductive behaviors in rats
Steinberg, R. M., Juenger, T. E., & Gore, A. C. (2007) · Hormones and Behavior · doi:10.1016/j.yhbeh.2006.12.004 · Cited by 87
Self-citationCan endocrine disruptors influence neuroplasticity in the aging brain?
Weiss, B. (2007) · NeuroToxicology · doi:10.1016/j.neuro.2007.01.012 · Cited by 34
Metadata
- Authors
- Gore, A. C., Heindel, J. J., & Zoeller, R. T.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2006-06
- Volume
- 147
- Issue
- 6
- Pages
- s1-s3
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2157188468
- Cited by
- 76
- References
- 3
- FWCI
- 3.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Endocrine Disruption for Endocrinologists (and Others). https://app.cochat.ai/papers/10.1210/en.2005-1367
- The paper
- Gore, A. C., Heindel, J. J., & Zoeller, R. T. (2006). Endocrine Disruption for Endocrinologists (and Others). Endocrinology. https://doi.org/10.1210/en.2005-1367
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.